Active substance
Mebeverine
- SFDA 13
- NHS prices 3
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| BEVACOL 135MG TABLET | 135 mg | Film-coated tablet · Oral use | 32 Blister | SAR 14.45 | Generic · Prescription | The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM) | Valid |
| DUSPAMEN | 135 mg | Tablet · Oral use | 150 Blister | SAR 80.40 | Generic · Prescription | Jazeera Pharmaceutical Industries (JPI) | Valid |
| DUSPAMEN 135MG TAB | 135 mg | Film-coated tablet · Oral use | 30 Blister | SAR 20.70 | Generic · Prescription | Jazeera Pharmaceutical Industries (JPI) | Valid |
| DUSPAMEN 200 mg prolonged release capsule | 200 mg | modified-release tablet · Oral use | 30 Blister | SAR 40.90 | Generic · Prescription | Jazeera Pharmaceutical Industries (JPI) | Valid |
| DUSPATALIN 200MG PROLONGED RELEASE CAPS | 200 mg | Modified-release capsule · Oral use | 30 Blister | SAR 48.15 | Generic · Prescription | ABBOTT BIOLOGICALS | Valid |
| MEBAGEN | 135 mg | Film-coated tablet · Oral use | 30 Blister | SAR 21.65 | Generic · Prescription | RIYADH PHARMA | Valid |
| MEBAGEN SR 200MG CAPSULE | 200 mg | Capsule · Oral use | 30 Blister | SAR 40.90 | Generic · Prescription | RIYADH PHARMA | Valid |
| MEVA 135MG F.C.TABLET | 135 mg | Film-coated tablet · Oral use | 30 Blister | SAR 15.80 | Generic · Prescription | Jamjoom Pharmaceuticals Factory Company | Valid |
| Meva SR | 200 mg | Modified-release capsule, hard · Oral use | 30 Blister | SAR 40.90 | Generic · Prescription | Jamjoom Pharmaceuticals Factory Company | Valid |
| SPASMOTALIN 100MG TAB | 100 mg | Tablet · Oral use | 20 Blister | SAR 11.75 | NCE · Prescription | ALAMRIAH FOR PHARMACEUTICALS INDUSTRIES | Valid |
| VERINE 135MG TAB | 135 mg | Tablet · Oral use | 30 Blister | SAR 21.65 | Generic · Prescription | SPIMACO ADDWAEIH | Valid |
| VERINE SR 200MG SUSTAINED RELEASED CAP | 200 mg | Modified-release capsule · Oral use | 30 Blister | SAR 43.20 | Generic · Prescription | SPIMACO ADDWAEIH | Valid |
| DUSPATALIN 135MGTAB | 135 mg | Tablet · Oral use | 30 Blister | SAR 25.95 | Generic · Prescription | SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
ABDOMINAL SPASM; IRRITABLE BOWEL SYNDROME
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| NHS Drug Tariff | Mebeverine 135mg tablets | £3.06 | 100 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Mebeverine 200mg modified-release capsules | £9.98 | 60 capsule | 1 Oct 2026 |
| NHS Drug Tariff | Mebeverine 50mg/5ml oral suspension sugar free | £115.29 | 300 ml | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.